Sigrid Therapeutics rakes in $1.6 mln
Stockholm-based Sigrid Therapeutics, which is developing a device to lower blood sugar levels, has raised $1.6 million in funding. Joyance Partners and Pär Gellerfors led the round.
5 September 2019•1 min read
Stockholm-based Sigrid Therapeutics, which is developing a device to lower blood sugar levels, has raised $1.6 million in funding. Joyance Partners and Pär Gellerfors led the round.
